Acetazolamide

In some countries, this medicine may only be approved for veterinary use.

In the US, Acetazolamide (acetazolamide systemic) is a member of the following drug classes: carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors and is used to treat Edema, Epilepsy, Glaucoma, Hydrocephalus, Mountain Sickness / Altitude Sickness, Pseudotumor Cerebri and Seizure Prevention.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01EC01

CAS registry number (Chemical Abstracts Service)

0000059-66-5

Chemical Formula

C4-H6-N4-O3-S2

Molecular Weight

222

Therapeutic Categories

Glaucoma treatment

Diuretic agent

Carbonic anhydrase inhibitor

Chemical Names

N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide (BAN, JAN)

2-Acetamido-1,3,4-thiadiazole-5-sulfonamide (WHO)

Foreign Names

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web4)